Evidence map›Paper›PMID 33525952›Full record

ArticleJournal of telemedicine and telecare2023

The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications.

Ayla M Tourkmani, Turki J ALHarbi, Abdulaziz M Bin Rsheed, Alian A Alrasheedy, Wedad ALMadani, Fahad ALJuraisi, Azzam Fahad AlOtaibi, Mohammed AlHarbi, Abood F AlAbood, Abdulaziz A Ibn Alshaikh

Open access · bronzeAbstract read
In one paragraph

Article in Journal of telemedicine and telecare, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 6 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 6 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Diabetes Technology in Saudi Arabia: Current Status and Future Directions.Journal of diabetes science and technology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Patient journey for hypertension and dyslipidemia in Saudi Arabia: highlighting the evidence gaps.Archives of public health = Archives belges de sante publique · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ayla M TourkmaniChronic Illness Center, Family and Community Medicine Department, Prince Sultan Military Medical City, Saudi Arabia.
Turki J ALHarbiChronic Illness Center, Family and Community Medicine Department, Prince Sultan Military Medical City, Saudi Arabia.
Abdulaziz M Bin RsheedChronic Illness Center, Family and Community Medicine Department, Prince Sultan Military Medical City, Saudi Arabia.
Alian A AlrasheedyDepartment of Pharmacy Practice, College of Pharmacy, Qassim University, Buraidah, Saudi Arabia.ORCID 0000-0003-3617-7425
Wedad ALMadaniNational Center for Evidence based Health Practice, Saudi Health Council, Saudi Arabia.
Fahad ALJuraisiArmed Forces Medical Services Directorate, Riyadh, Saudi Arabia.
Azzam Fahad AlOtaibiChronic Illness Center, Family and Community Medicine Department, Prince Sultan Military Medical City, Saudi Arabia.
Mohammed AlHarbiFamily and community Medicine, College of Medicine, Majmaah University, Saudi Arabia.
Abood F AlAboodArmed Forces Medical Services Directorate, Riyadh, Saudi Arabia.
Abdulaziz A Ibn AlshaikhArmed Forces Medical Services Directorate, Riyadh, Saudi Arabia.
Riyadh Armed Forces Hospital · SAMajmaah University · SAQassim University · SASaudi Center for Disease Prevention and Control · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRoutine diabetes care changed during the COVID-19 pandemic due to precautionary measures such as lockdowns, cancellation of in-person visits, and patients' fear of being infected when attending clinics. Because of the pandemic, virtual clinics were implemented to provide diabetes care. Therefore, we conducted this study to assess the impact of these virtual clinics on glycaemic control among high-risk patients with type 2 diabetes mellitus (DM).

methodsA prospective single-cohort pre-/post telemedicine care intervention study was conducted on 130 patients with type 2 DM attending a virtual integrated care clinic at a chronic Illness center in a family and community medicine department in Riyadh, Saudi Arabia during the COVID-19 pandemic.

resultsThe mean age of the participants was 57 years (standard deviation (SD) = 12) and the mean (SD) duration of diabetes was 14 (7) years. Over a period of 4 months, the HbA1c decreased significantly from 9.98 ± 1.33 pre-intervention to 8.32 ± 1.31 post-intervention (mean difference 1.66 ± 1.29; CI = 1.43-1.88; DISCUSSION: The current study found a significant positive impact of telemedicine care on glycaemic control among high-risk patients with DM during the COVID-19 pandemic. Moreover, it showed that telemedicine could be integrated into diabetic care to successfully replace many of the usual in-person care visits. Consequently, health policy makers need to consider developing comprehensive guidelines in Saudi Arabia for telemedicine care to, ensure the quality of care and address issues such as financial reimbursement and patient information privacy.

Indexed as

COVID-19Diabetes Mellitus, Type 2TelemedicineCommunicable Disease ControlHumansMiddle AgedPandemicsProspective StudiesSaudi ArabiaCOVID-19Saudi ArabiaTelemedicineuncontrolled diabetes mellitus

Identifiers

PMID33525952
PMCPMC10195693
OpenAlexW3127284261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.